.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Covington
Harvard Business School
Cipla
Federal Trade Commission
Cerilliant
Baxter
Cantor Fitzgerald
Accenture
QuintilesIMS

Generated: December 12, 2017

DrugPatentWatch Database Preview

Bracco Company Profile

« Back to Dashboard

What is the competitive landscape for BRACCO, and when can generic versions of BRACCO drugs launch?

BRACCO has forty-three approved drugs.

There are three US patents protecting BRACCO drugs.

There are one hundred and fifty-six patent family members on BRACCO drugs in twenty-eight countries and thirty-eight supplementary protection certificates in nine countries.

Summary for Bracco

International Patents:156
US Patents:3
Tradenames:65
Ingredients:37
NDAs:43
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
BraccoRENOVIST IIdiatrizoate meglumine; diatrizoate sodiumINJECTABLE;INJECTION010040-019Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BraccoLUMENHANCEmanganese chloride tetrahydrateFOR SOLUTION;ORAL020686-001Dec 19, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BraccoCHOLOVUEiodoxamate meglumineINJECTABLE;INJECTION018076-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BraccoRENOCAL-76diatrizoate meglumine; diatrizoate sodiumINJECTABLE;INJECTION089347-001Jun 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BraccoLIQUID E-Z-PAQUEbarium sulfateSUSPENSION;ORAL208143-003Mar 1, 2017RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
BraccoROBENGATOPErose bengal sodium i-131INJECTABLE;INJECTION016224-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BraccoISOVUE-300iopamidolINJECTABLE;INJECTION020327-003Oct 12, 1994RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
BraccoIODOTOPEsodium iodide i-131CAPSULE;ORAL010929-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BraccoSONORXsimethicone-celluloseSUSPENSION;ORAL020773-001Oct 29, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BraccoRENO-60diatrizoate meglumineINJECTABLE;INJECTION010040-016Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Bracco

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
BraccoPROHANCEgadoteridolINJECTABLE;INJECTION020131-001Nov 16, 1992► Subscribe► Subscribe
BraccoPROHANCEgadoteridolINJECTABLE;INJECTION020131-001Nov 16, 1992► Subscribe► Subscribe
BraccoISOVUE-200iopamidolINJECTABLE;INJECTION020327-001Oct 12, 1994► Subscribe► Subscribe
BraccoPROHANCE MULTIPACKgadoteridolINJECTABLE;INJECTION021489-001Oct 9, 2003► Subscribe► Subscribe
BraccoISOVUE-M 300iopamidolINJECTABLE;INJECTION018735-004Dec 31, 1985► Subscribe► Subscribe
BraccoISOVUE-370iopamidolINJECTABLE;INJECTION018735-003Dec 31, 1985► Subscribe► Subscribe
BraccoCARDIOGEN-82rubidium chloride rb-82INJECTABLE;INJECTION019414-001Dec 29, 1989► Subscribe► Subscribe
BraccoPROHANCE MULTIPACKgadoteridolINJECTABLE;INJECTION021489-001Oct 9, 2003► Subscribe► Subscribe
BraccoMULTIHANCEgadobenate dimeglumineINJECTABLE;INTRAVENOUS021357-001Nov 23, 2004► Subscribe► Subscribe
BraccoISOVUE-250iopamidolINJECTABLE;INJECTION018735-007Jul 6, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Bracco

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,110,443 Dry stable formation to produce microbubble suspension for ultrasound► Subscribe
5,908,610 Stable microbubble suspensions comprising saturated phospholipios for ultrasonic echography► Subscribe
5,567,414 Stable microbubbles suspensions injectable into living organisms► Subscribe
6,136,293 Stable microbubbles suspensions containing saturated lamellar phospholipids► Subscribe
RE39146Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof► Subscribe
5,863,520 Method of echographic imaging using polymeric gas or air filled microballoons► Subscribe
7,083,778Ultrasound contrast agents and methods of making and using them► Subscribe
7,033,574Stable microbubbles suspensions injectable into living organisms► Subscribe
5,711,933 Method of making polymeric gas or air filled microballoons for ultrasonic echography► Subscribe
5,271,928 Stable microbubbles suspensions injectable into living organisms► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Bracco Drugs

Country Document Number Estimated Expiration
JapanH07503254► Subscribe
Germany69307351► Subscribe
Hungary226007► Subscribe
Netherlands300061► Subscribe
JapanH04506670► Subscribe
Australia1033095► Subscribe
Ireland69018► Subscribe
Iceland1739► Subscribe
South Korea100216138► Subscribe
Germany69111719► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Bracco Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB97/078United Kingdom► SubscribePRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
90018-6Sweden► SubscribePRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
0736Netherlands► SubscribePRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
C/GB08/036United Kingdom► SubscribePRODUCT NAME: MICAFUNGIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF IN PARTICULAR MICAFUNGIN SODIUM; REGISTERED: UK EU/1/08/448/001 20080425; UK EU/1/08/448/002 20080425
14/032Ireland► SubscribePRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTRATION NO/DATE: EU/1/13/892/001-002 20140121
99C0030Belgium► SubscribePRODUCT NAME: RABEPRAZOLE SODIUM; NAT. REGISTRATION NO/DATE: 5532 IE 1 F 3 19990201; FIRST REGISTRATION: GB 10555/0010 19980508
2015 00014Denmark► SubscribePRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
90064-1Sweden► SubscribePRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
00061Netherlands► SubscribePRODUCT NAME: ZWAVELHEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001-002 20010326
C0036France► SubscribePRODUCT NAME: SULPHUR HEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001 20010326
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Healthtrust
Colorcon
McKinsey
Harvard Business School
QuintilesIMS
Baxter
Moodys
US Army
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot